People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gynesonics, Inc | — | Other Health Care | Series C | $299.1M | $1.0B | 2012 |
| Precipio, Inc. | — | Biotechnology | Series B | $67.0M | $32.2M | 2017 |
| USDS, Inc. | — | Other Health Care | Series A | $6.1M | $92.4M | 2010 |
Doug Fisher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Doug Fisher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Cohen | 1 | 38 |
| Robert Brown | 1 | 22 |
| Arnold Oronsky | 1 | 10 |
| JEFFREY SCHWARTZ | 1 | 9 |
| Joyce Erony | 1 | 8 |
| Stephen Davis | 1 | 8 |
| Jonathan MacQuitty | 1 | 7 |
| David Neustaedter | 1 | 7 |
| Antonius Schuh | 1 | 5 |
| Michael Luther | 1 | 4 |
| Tom Rodgers | 1 | 4 |
| Rodney Markin | 1 | 4 |
| Darrin Uecker | 1 | 3 |
| Christopher M Owens | 1 | 3 |
| Karen Talmadge | 1 | 3 |
| Mike Carusi | 1 | 3 |
| Alan Mendelson | 1 | 3 |
| RODNEY S MARKIN | 1 | 3 |
| Mark McClellan | 1 | 3 |
| Chandra Leo | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.